![Hans-Peter Torsten Ekre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans-Peter Torsten Ekre
Fondateur chez
NEXTCELL PHARMA AB
Profil
Hans-Peter Torsten Ekre is the founder of Dilafor AB, founded in 2003, and NextCell Pharma AB, founded in 2014, where the title held is Chairman.
Current jobs include Executive Chairman at Bactaviva AB, Director at IMED AB, Managing Director at KCIF Fund Management AB, and Director at ProNoxis AB. Former jobs include Chairman at HBV Theranostica AB and NovaSAID AB; Director-Research & Development at Astra AB from 1991 to 2000; Director at KDev Exploratory AB, Avaris AB, Cytoguide ApS, Bioneris AB, and Palette Life Sciences AB; Manager-Research & Development at Pharmacia AB from 1976 to 1991; Investment Manager at Karolinska Development AB (Private Equity) from 2006 to 2012; and Investment Manager at KDventures AB from 2003 to 2012.
Education includes graduate studies at the University of Stockholm.
Postes actifs de Hans-Peter Torsten Ekre
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCELL PHARMA AB | Fondateur | 19/03/2014 |
KCIF Fund Management AB | Directeur Général | 21/04/2011 |
IMED AB
 IMED AB Drugstore ChainsRetail Trade Develops human antibodies for immuno-modulation of diseases as Graft-Versus-Host Disease | Directeur/Membre du Conseil | 26/11/2009 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Directeur/Membre du Conseil | 28/12/2009 |
Bactaviva AB | Président | - |
Anciens postes connus de Hans-Peter Torsten Ekre
| Sociétés | Poste | Fin |
|---|---|---|
Cytoguide ApS
 Cytoguide ApS Pharmaceuticals: MajorHealth Technology Develops component drugs that target receptors on cells of the immune system | Directeur/Membre du Conseil | 20/05/2014 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Private Equity Investor | 31/12/2012 |
Bioneris AB
 Bioneris AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research services | Directeur/Membre du Conseil | 19/01/2012 |
| KDVENTURES AB | Directeur en chef des Investissements | 01/01/2012 |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Hans-Peter Torsten Ekre
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals preparations | Health Technology |
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMED AB
IMED AB Drugstore ChainsRetail Trade Develops human antibodies for immuno-modulation of diseases as Graft-Versus-Host Disease | Retail Trade |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services Provides drug discovery solutions | Commercial Services |
Avaris AB
 Avaris AB Miscellaneous Commercial ServicesCommercial Services Provides cancer therapies based on gen- and cell-therapy | Commercial Services |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products from heparin derivatives | Health Technology |
Cytoguide ApS
Cytoguide ApS Pharmaceuticals: MajorHealth Technology Develops component drugs that target receptors on cells of the immune system | Health Technology |
KCIF Fund Management AB | |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
Bioneris AB
Bioneris AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research services | Health Technology |
HBV Theranostica AB
 HBV Theranostica AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research services | Health Technology |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Develops products that improve the quality of life for patients | Health Technology |
NextCell Pharma AB
 NextCell Pharma AB Pharmaceuticals: MajorHealth Technology Develops investigational medicinal products | Health Technology |
Bactaviva AB |
